Objective To explore the use of ChatGPT (Chat Generative Pre-trained Transformer) in pediatric diagnosis, treatment and doctor-patient communication, evaluate the professionalism and accuracy of the medical advice provided, and assess its ability to provide psychological support. Methods The knowledge databases of ChatGPT 3.5 and 4.0 versions as of April 2023 were selected. A total of 30 diagnosis and treatment questions and 10 doctor-patient communication questions regarding the pediatric urinary system were submitted to ChatGPT versions 3.5 and 4.0, and the answers to ChatGPT were evaluated. Results The answers to the 40 questions answered by ChatGPT versions 3.5 and 4.0 all reached the qualified level. The answers to 30 diagnostic and treatment questions in ChatGPT 4.0 version were superior to those in ChatGPT 3.5 version (P=0.024). There was no statistically significant difference in the answers to the 10 doctor-patient communication questions answered by ChatGPT 3.5 and 4.0 versions (P=0.727). For prevention, single symptom, and disease diagnosis and treatment questions, ChatGPT’s answer scores were relatively high. For questions related to the diagnosis and treatment of complex medical conditions, ChatGPT’s answer scores were relatively low. Conclusion ChatGPT has certain value in assisting pediatric diagnosis, treatment and doctor-patient communication, but the medical advice provided by ChatGPT cannot completely replace the professional judgment and personal care of doctors.
Valvular heart disease (VHD) ranks as the third most prevalent cardiovascular disease, following coronary artery disease and hypertension. Severe cases can lead to ventricular hypertrophy or heart failure, highlighting the critical importance of early detection. In recent years, the application of deep learning techniques in the auxiliary diagnosis of VHD has made significant advancements, greatly improving detection accuracy. This review begins by introducing the etiology, pathological mechanisms, and impact of common valvular heart diseases. It then explores the advantages and limitations of using electrocardiographic signals, phonocardiographic signals, and multimodal data in VHD detection. A comparison is made between traditional risk prediction methods and large language models (LLMs) for predicting cardiovascular disease risk, emphasizing the potential of LLMs in risk prediction. Lastly, the current challenges faced by deep learning in this field are discussed, and future research directions are proposed.